Christopher Iriarte, MD
Basic profileDirector of Supportive Oncodermatology and Director of the Inpatient Dermatology Consult Service, Department of Dermatology · Beth Israel Deaconess Medical Center
Christopher Iriarte is Director of Supportive Oncodermatology and Director of the Inpatient Dermatology Consult Service, Department of Dermatology at Beth Israel Deaconess Medical Center. OpenAlex indexes 39 publications with 327 citations (h-index 7).
Overview
Updated 27 Oct 2026
Christopher Iriarte, MD, is Director of Supportive Oncodermatology and Director of the Inpatient Dermatology Consult Service, Department of Dermatology at Beth Israel Deaconess Medical Center. The public record shows 40 publications with 330 citations (h-index 7), centered on Chemotherapy-related skin toxicity, Drug-Induced Adverse Reactions, Dermatology and Skin Diseases.
- Most recent indexed publication: 2023 · Pediatric dermatology
- Top research focus: Chemotherapy-related skin toxicity
Generated from the cited public record · current as of 27 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 6.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
25.1%Corticosteroid25.1%Betamethasone Diprop Augmented45%Clobetasol Propionate39%Hydrocortisone16%Part D≥25 patientsDermatology
21.6%Corticosteroid18.2%Triamcinolone Acetonide100%Part D≥47 patientsInterleukin-4 Receptor alpha Antagonist3.5%Dupixent Pen100%Part D<11 patientsAnti-infectives
17%Azole Antifungal17%Ketoconazole100%Part D≥24 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Updated 27 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Warts in pediatric oncology patients: A single-institution retrospective study.
Pediatric dermatology
Article2023 - Acral pigmented Spitz nevus in a child with transepidermal migration of melanocytes: Dermoscopic and reflectance confocal microscopic features.
Pediatric dermatology
Case Report2018
Most-cited works
by citation count (OpenAlex)- 01Review of applications of microneedling in dermatologyReview194 citations2017
- 02
- 03
- 04
- 05
Network
Updated 27 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 27 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →meetings-external.aad.org ↗
- Graduate
George Washington University School of Medicine and Health Sciences
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →files.constantcontact.com ↗ - Combined residency in dermatology and internal medicine
Harvard Combined Internal Medicine-Dermatology Program
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →files.constantcontact.com ↗ - Board certified
American Board of Dermatology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medifind.com ↗
Editorial & leadership roles
journal and society appointments- Fellow
American Academy of Dermatology (FAAD)
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →meetings-external.aad.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Matcheri Keshavan, MD
Beth Israel Deaconess Medical Center
Connie Tsao, MD
Beth Israel Deaconess Medical Center
Donald Cutlip, MD
Beth Israel Deaconess Medical Center
Robert Yeh, MD
Beth Israel Deaconess Medical Center
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”